Gerresheimer AG is to build a new plant in Skopje, Republic of North Macedonia. “As part of our growth strategy, we require additional manufacturing capacity and are expanding our European production network. We will build a new plant in Skopje to produce plastic systems for both the pharmaceutical industry and the medical technology sector as well as prefillable syringes. North Macedonia is an ideal location for expanding our production. The country offers good infrastructure, cost structures, trained personnel and excellent support from the authorities,” said Dietmar Siemssen, Chief Execu- tive Officer of Gerresheimer AG.
Gerresheimer is investing a mid-double-digit million Euro figure in the new plant in the North Macedonian capital of Skopje, an amount that is already included inthe company’s medium-term investment plans. Construction will begin in the first half of 2019, with completion scheduled for the first half of 2020. It is expected that start of production will take place in the second half of 2020. The plant will initially manufacture medical plastic systems prior to adding prefillable glass syringes lines following a further expansion phase. Up to 400 jobs may be created in the medium term. The plant will belong to the Plastics & Devices Division where it will fall under the Medical Systems Business Unit. Construction work, staff training and production ramp-up will be closely supervised and supported by the Gerresheimer competence center in Wackersdorf, Germany, together with European sister factories in Pfreimd and Buende in Germany as well as Horsovsky Tyn in the Czech Republic. Gerresheimer has production facilities in North and South America as well as in Europe and Asia. The Skopje plant will be Gerresheimer’s first in South-Eastern Europe.
About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers.
With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharma- ceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, micro pumps, prefillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.
07.03.2019, Gerresheimer AG
Les informations publiées sur notre portail sont soumises au droit d´auteur et appartiennent à la société en question resp. à la source des nouvelles. Tous les droits sont réservés expressément. N´importe quel utilisateur qui accède à un tel matériel peut faire ainsi seulement pour sa propre utilisation personnelle, et l´usage d´un tel matériel est au risque unique de l´utilisateur. La redistribution ou toute autre exploitation commerciale d´un tel matériel de nouvelles est expressément interdite. Là où un tel matériel de nouvelles est fourni par un tiers, chaque utilisateur accepte d´observer et être lié par les limites spécifiques de l´utilisation s´appliquant à un tel matériel de nouvelles. Glass Global ne représente ou n´approuve pas l´exactitude ou la fiabilité d´aucune des informations citées dans les nouvelles ou pages externes auxquelles on se réfère ici.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.